HOME >> MEDICINE >> NEWS
Trial results have dramatically reduced HRT use

More than half (58%) of women stopped taking HRT after the publication of a large trial in 2002 concluded that it was not suitable for the prevention of chronic diseases, finds a study in this week's BMJ.

Six months after the trial results were published, researchers in New Zealand surveyed 776 women who were taking HRT.

Of 734 respondents, 423 (58%) had stopped taking HRT when the results were published, 132 (18%) had restarted at the time of the survey, and 291 (40%) had not.

Of the 132 women who restarted, 100 did so because of the return of symptoms, 16 because they "felt better" on HRT, and 15 for other reasons.

Most respondents (83%) reported that they had discussed HRT with a health professional. The authors also found that older age, use of combined HRT, and longer duration of HRT were associated with stopping HRT.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-20-7383-6529
BMJ-British Medical Journal
9-Oct-2003


Page: 1

Related medicine news :

1. Trial reveals safer and simpler approach to treating children with cystic fibrosis
2. Trials launched to test treatment of cognitive dysfunction in schizophrenia
3. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
4. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
5. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
6. Trial opens new possibilities for improving survival with a novel heart attack drug
7. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
8. National Lung Screening Trial
9. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
10. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
11. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... OLATHE, Kan. (PRWEB) , ... June 15, 2019 , ... ... to traumatic experiences, poverty, untreated mental health needs and lack of a support network, ... decision is made to remove the children from the home and place them with ...
(Date:6/14/2019)... , ... June 14, 2019 , ... ... Tempur-Pedic® Mattress & Pink Bag Event® scheduled for Saturday, July 13th. UBCF is ... men and children directly impacted by breast cancer. This second event was added ...
(Date:6/13/2019)... ... 2019 , ... Endometriosis is a painful, inflammatory disease that occurs when tissue grows outside of ... , Heavy bleeding , Irregular menstruation , Severe cramps ... uses the latest and newest treatment protocols in dealing with the symptoms of endometriosis. In ...
(Date:6/13/2019)... ... June 13, 2019 , ... Charm Sciences, Inc. ... has been accepted by the 2019 National Conference of Interstate Milk Shipments for ... , The Charm BL30SEC test was validated by third party laboratories working in ...
(Date:6/13/2019)... ... 13, 2019 , ... Hard money lenders like Monroe Funding Corporation are able ... also be provided quickly. If the documentation and collateral are immediately available, it’s possible ... the federal oversight involved with a traditional lender, which allows loans to be customized ...
Breaking Medicine News(10 mins):
(Date:6/19/2019)... ... June 19, 2019 , ... ... vitro toxicology testing solutions, announced the addition of the Human MDR-1 / ... in vitro toxicology offerings and allows researchers to perform critical toxicology testing previously ...
(Date:6/18/2019)... ... June 18, 2019 , ... Officials with ... management services, are pleased to announce the acquisition of Leading Edge Medical Associates ... LEMA’s 34 physicians and 9 advanced practice clinicians care for 115,000 emergency department ...
(Date:6/16/2019)... United Kingdom (PRWEB) , ... June 15, 2019 ... ... http://www.lycote.com , has just published results of a clinical study on its new ... the company used different nutraceutical capsule and chocolate formulations, which were based on ...
Breaking Medicine Technology:
Cached News: